A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer

Breast Cancer Research and Treatment
M RudolphB Ramaswamy

Abstract

High expression of glioma-associated oncogene homolog-1 (GLI1) is associated with poor prognosis in estrogen receptor (ER) positive breast cancers. We sought to define a GLI1-dependent gene signature in ER-positive tumors that could further stratify patients at higher risk for disease recurrence and potentially lead to novel combination therapies. We identified an inverse correlation between GLI1 expression and distant disease-free survival (DFS) using a dataset developed at MD Anderson Cancer Center (Hatzis dataset) containing clinical data from 508 breast cancer patients. Using a qPCR-based microarray platform, we identified genes differentially regulated by GLI1 in MCF7 cells and then determined if expression of these genes correlated with GLI1 expression in patient tumor samples. Statistical comparison between the groups was performed by ANOVA. Direct comparison of two groups was done by a two-tailed t test. Correlations between variables were done by Pearson's method. Expression of GLI1 and its target genes correlated significantly with worse distant DFS in breast cancer patients with Luminal A molecular subtype. Particularly, co-expression of GLI1 with EGFR and/or SNAI1, two of the identified GLI1 targets, was predictive ...Continue Reading

References

Oct 1, 1988·Molecular and Cellular Endocrinology·D L ManningC D Green
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R I NicholsonR W Blamey
Aug 31, 2002·Science·David M BermanPhilip A Beachy
Jul 8, 2003·The Journal of Pathology·Caroline J WittonJohn M S Bartlett
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Grazia ArpinoRichard M Elledge
Jun 30, 2005·International Journal of Cancer. Journal International Du Cancer·Grit KasperKerstin Lehmann
Jan 24, 2006·Molecular Cell·Xiaolong WeiDonald Kufe
Sep 17, 2008·Genes & Development·Markku Varjosalo, Jussi Taipale
Apr 25, 2009·International Journal of Cancer. Journal International Du Cancer·Salman M HyderJianbo Wu
Mar 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K David VoducHagen Kennecke
Feb 8, 2011·Hormone Molecular Biology and Clinical Investigation·Surojeet SenguptaV Craig Jordan
May 12, 2011·JAMA : the Journal of the American Medical Association·Christos HatzisW Fraser Symmans
Oct 4, 2011·The Journal of Clinical Investigation·Hege G RussnesAnne-Lise Borresen-Dale
Jun 30, 2012·Nature Methods·Johannes SchindelinAlbert Cardona
Sep 20, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Reina HaqueMichael F Press
May 31, 2013·Nature Reviews. Molecular Cell Biology·James Briscoe, Pascal P Thérond
Oct 8, 2013·Breast Cancer Research and Treatment·Giovanni CirielloNikolaus Schultz
Feb 14, 2015·Breast Cancer Research : BCR·Michael J DuffyManfred Schmitt
Apr 23, 2015·Endocrine-related Cancer·Felicity E B May, Bruce R Westley

❮ Previous
Next ❯

Citations

Mar 15, 2019·Breast Cancer Research and Treatment·Chengxiao YuYue Jiang
Jun 25, 2020·Cancer Metastasis Reviews·Belinda J Petri, Carolyn M Klinge
Aug 10, 2019·Cancers·Priyanka BhatejaBhuvaneswari Ramaswamy
May 12, 2020·Frontiers in Molecular Biosciences·Deguang KongHeide L Ford
Jan 9, 2021·Journal of Cellular Biochemistry·Julia KuehnMartin Götte
May 23, 2021·Pathology, Research and Practice·Araceli García-MartínezGloria Peiró
May 10, 2020·Current Radiopharmaceuticals·Ulku Korkmaz, Funda Ustun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.